Navigation Links
PDL BioPharma to Announce Third Quarter 2010 Financial Results on November 10, 2010
Date:11/2/2010

INCLINE VILLAGE, Nev., Nov. 2, 2010 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that the Company will release its third quarter financial results on Wednesday, November 10, 2010 after the markets close. PDL's management will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results.  

Conference Call Details

To access the live conference call via phone, please dial (866) 271-5140 from the United States and Canada or (617) 213-8893 internationally. The conference ID is 98631412. Please dial in approximately ten minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 17, 2010, and may be accessed by dialing (888) 286-8010 from the United States and Canada or (617) 801-6888 internationally. The replay passcode is 74992654.

To access the live and subsequently archived webcast of the conference call, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo ar
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Researchers prolong the half-life of biopharmaceutical proteins
2. Science survey ranks top biopharma employers
3. GREENBioPharma -- Dec. 2-3, 2009
4. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
5. 2008 SNM Wagner-Torizuka Fellowships announced
6. NIAID announces 25 new awards to develop radiation countermeasures
7. Aware Announces Q3 2008 Earnings Conference Call
8. Governor Doyle announces historic genomic research collaboration
9. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
10. San Diego Supercomputer Center and UCSD announce Triton Resource
11. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2015)... , Aug. 20, 2015   Sensory, ... on improving the user experience and security of ... technologies, today announced that its TrulySecure™ ... authentication software to be FIDO Certified™. ... for compliance with the FIDO UAF (Universal Authentication ...
(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
... in some regions and increasing global demand for high ... water globally. This was the main conclusion of a ... Education. The special report follows a strategic workshop ... rules of international trade" held on 25th - 26th ...
... at the Genome Institute of Singapore (GIS) have, for ... comes with a guarantee on its reliability when reconstructing ... streamlined process for reconstructing and studying genomic sequences. ... of Computational and Mathematical Biology at the GIS, was ...
... fish have a greater capacity to cope with rising sea ... The discovery, by researchers at the ARC Centre of ... sheds a ray of hope amid the rising concern over ... levels of global warming expected to occur by the end ...
Cached Biology News:Experts call on governments, industries and the water and trade research communities 2Researchers at GIS develop systematic approach for accurate DNA sequence reconstruction 2When the heat's on, fish can cope 2When the heat's on, fish can cope 3
(Date:9/2/2015)... ... September 02, 2015 , ... ... compliance, quality systems, analytical testing, education and consulting services for the medical ... medical device products/processes development, design control, validation, quality assurance and regulatory compliance. ...
(Date:9/2/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Biomarkers - ... This report follows the broad definition ... be objectively measured and evaluated as an indicator ... as pharmacological responses to a therapeutic intervention. Tests ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... and plant-derived compounds. BCC Research reveals in its new report that the ... market defines the category and generates the most market demand. , BCC ...
(Date:9/2/2015)... 2, 2015 Veracyte, Inc. (NASDAQ: VCYT ... president and chief executive officer, will present at the ... 2015 at 10:30 a.m. ET in New ... audio webcast and subsequent replay may be accessed by ... available shortly after conclusion of the presentation and archived ...
Breaking Biology Technology:NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 2NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 3NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 4NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 5NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 6NSF International Strengthens Medical Device Consulting With Acquisition of Avarent LLC 7Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2
... StemCyte Inc. today announced,that Chief Scientific Officer Ram ... on the StemCyte,s Indian joint venture at the TiEcon,2008 ... during the session on "Stem Cells - The Future,Promise ... May 17. His,presentation will include information about the development ...
... May 16 The landscape of scientific,publications strategy, ... of,transparency guidelines. Half of global publications groups are ... foresee a shift,to medical groups to increase clinical ... Practices, LLC., In a benchmarking study that ...
... Novasep have,extended their partnership to develop large scale ... systems and equipment,will meet the growing needs of ... instruments for gram to industrial,scale production of high ... is to combine Chromatide,s experience,in solid phase synthesis ...
Cached Biology Technology:StemCyte Chief Scientific Officer to Present Company Overview with Focus on Indian Joint Venture at TiEcon 2008 2Industry Executives Finding Value in Shift of Scientific Publications 2Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology. 2Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology. 3Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology. 4